Botanicals and the metabolic syndrome

William T. Cefalu; Jianping Ye; Aamir Zuberi; David M. Ribnicky; Ilya Raskin; Zhijun Liu; Zhong Q. Wang; Phillip J. Brantley; Luke Howard; Michael Lefevre

doi:10.1093/ajcn/87.2.481s

Botanicals and the metabolic syndrome

William T. Cefalu, Jianping Ye, Aamir Zuberi, David M. Ribnicky, Ilya Raskin, Zhijun Liu, Zhong Q. Wang, Phillip J. Brantley, Luke Howard, Michael Lefevre

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Abstract

Metabolic syndrome describes the human condition characterized by the presence of coexisting traditional risk factors for cardiovascular disease, such as hypertension, dyslipidemia, glucose intolerance, and obesity, in addition to nontraditional cardiovascular disease risk factors, such as inflammatory processes and abnormalities of the blood coagulation system. Although the specific etiology for metabolic syndrome is not known, insulin resistance - a clinical state in which a normal or elevated insulin concentration reflects an impaired biological response - is present and is considered a key pathophysiologic abnormality. As such, metabolic syndrome can be considered to be a prediabetic state and contributes greatly to increased morbidity and mortality in humans. Given the public health significance of metabolic syndrome, successful strategies are direly needed to intervene in its development. As such, nutritional supplementation with botanicals that effectively address pathogenic mechanisms, combined with the acceptance and widespread use of botanical supplements by the general public, represents an attractive, novel, and potentially effective approach to the problem. Thus, the overall goal of our botanical research center is to comprehensively evaluate botanicals in addressing the pathophysiologic mechanisms that lead to the development of insulin resistance and metabolic syndrome. Currently, each of the 3 research projects evaluates a specific botanical [Russian tarragon (Artemisia dracunculus L), shilianhua (Sinocrassula indica), and grape (Vitus vinifera) anthocyanins] and assesses the effect on pathogenic mechanisms leading to the development of insulin resistance. With the completion of our research, we anticipate a better understanding of the cellular mechanisms by which insulin resistance develops and the role of botanicals in modulating the progression to metabolic syndrome.

Original language	American English
Pages (from-to)	481S-487S
Journal	American Journal of Clinical Nutrition
Volume	87
Issue number	2
DOIs	https://doi.org/10.1093/ajcn/87.2.481s
State	Published - Jan 2 2008
Externally published	Yes

ASJC Scopus subject areas

Medicine (miscellaneous)
Nutrition and Dietetics

Keywords

Anthocyanins
Artemisia dracunculus L
Botanicals
Insulin
Insulin resistance
Shilianhua

Access to Document

10.1093/ajcn/87.2.481s

Cite this

@article{dc2503e47f4e4d569b129b741523b52f,

title = "Botanicals and the metabolic syndrome",

abstract = "Metabolic syndrome describes the human condition characterized by the presence of coexisting traditional risk factors for cardiovascular disease, such as hypertension, dyslipidemia, glucose intolerance, and obesity, in addition to nontraditional cardiovascular disease risk factors, such as inflammatory processes and abnormalities of the blood coagulation system. Although the specific etiology for metabolic syndrome is not known, insulin resistance - a clinical state in which a normal or elevated insulin concentration reflects an impaired biological response - is present and is considered a key pathophysiologic abnormality. As such, metabolic syndrome can be considered to be a prediabetic state and contributes greatly to increased morbidity and mortality in humans. Given the public health significance of metabolic syndrome, successful strategies are direly needed to intervene in its development. As such, nutritional supplementation with botanicals that effectively address pathogenic mechanisms, combined with the acceptance and widespread use of botanical supplements by the general public, represents an attractive, novel, and potentially effective approach to the problem. Thus, the overall goal of our botanical research center is to comprehensively evaluate botanicals in addressing the pathophysiologic mechanisms that lead to the development of insulin resistance and metabolic syndrome. Currently, each of the 3 research projects evaluates a specific botanical [Russian tarragon (Artemisia dracunculus L), shilianhua (Sinocrassula indica), and grape (Vitus vinifera) anthocyanins] and assesses the effect on pathogenic mechanisms leading to the development of insulin resistance. With the completion of our research, we anticipate a better understanding of the cellular mechanisms by which insulin resistance develops and the role of botanicals in modulating the progression to metabolic syndrome.",

keywords = "Anthocyanins, Artemisia dracunculus L, Botanicals, Insulin, Insulin resistance, Shilianhua",

author = "Cefalu, {William T.} and Jianping Ye and Aamir Zuberi and Ribnicky, {David M.} and Ilya Raskin and Zhijun Liu and Wang, {Zhong Q.} and Brantley, {Phillip J.} and Luke Howard and Michael Lefevre",

year = "2008",

month = jan,

day = "2",

doi = "10.1093/ajcn/87.2.481s",

language = "American English",

volume = "87",

pages = "481S--487S",

journal = "American Journal of Clinical Nutrition",

issn = "0002-9165",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Botanicals and the metabolic syndrome

AU - Cefalu, William T.

AU - Ye, Jianping

AU - Zuberi, Aamir

AU - Ribnicky, David M.

AU - Raskin, Ilya

AU - Liu, Zhijun

AU - Wang, Zhong Q.

AU - Brantley, Phillip J.

AU - Howard, Luke

AU - Lefevre, Michael

PY - 2008/1/2

Y1 - 2008/1/2

N2 - Metabolic syndrome describes the human condition characterized by the presence of coexisting traditional risk factors for cardiovascular disease, such as hypertension, dyslipidemia, glucose intolerance, and obesity, in addition to nontraditional cardiovascular disease risk factors, such as inflammatory processes and abnormalities of the blood coagulation system. Although the specific etiology for metabolic syndrome is not known, insulin resistance - a clinical state in which a normal or elevated insulin concentration reflects an impaired biological response - is present and is considered a key pathophysiologic abnormality. As such, metabolic syndrome can be considered to be a prediabetic state and contributes greatly to increased morbidity and mortality in humans. Given the public health significance of metabolic syndrome, successful strategies are direly needed to intervene in its development. As such, nutritional supplementation with botanicals that effectively address pathogenic mechanisms, combined with the acceptance and widespread use of botanical supplements by the general public, represents an attractive, novel, and potentially effective approach to the problem. Thus, the overall goal of our botanical research center is to comprehensively evaluate botanicals in addressing the pathophysiologic mechanisms that lead to the development of insulin resistance and metabolic syndrome. Currently, each of the 3 research projects evaluates a specific botanical [Russian tarragon (Artemisia dracunculus L), shilianhua (Sinocrassula indica), and grape (Vitus vinifera) anthocyanins] and assesses the effect on pathogenic mechanisms leading to the development of insulin resistance. With the completion of our research, we anticipate a better understanding of the cellular mechanisms by which insulin resistance develops and the role of botanicals in modulating the progression to metabolic syndrome.

AB - Metabolic syndrome describes the human condition characterized by the presence of coexisting traditional risk factors for cardiovascular disease, such as hypertension, dyslipidemia, glucose intolerance, and obesity, in addition to nontraditional cardiovascular disease risk factors, such as inflammatory processes and abnormalities of the blood coagulation system. Although the specific etiology for metabolic syndrome is not known, insulin resistance - a clinical state in which a normal or elevated insulin concentration reflects an impaired biological response - is present and is considered a key pathophysiologic abnormality. As such, metabolic syndrome can be considered to be a prediabetic state and contributes greatly to increased morbidity and mortality in humans. Given the public health significance of metabolic syndrome, successful strategies are direly needed to intervene in its development. As such, nutritional supplementation with botanicals that effectively address pathogenic mechanisms, combined with the acceptance and widespread use of botanical supplements by the general public, represents an attractive, novel, and potentially effective approach to the problem. Thus, the overall goal of our botanical research center is to comprehensively evaluate botanicals in addressing the pathophysiologic mechanisms that lead to the development of insulin resistance and metabolic syndrome. Currently, each of the 3 research projects evaluates a specific botanical [Russian tarragon (Artemisia dracunculus L), shilianhua (Sinocrassula indica), and grape (Vitus vinifera) anthocyanins] and assesses the effect on pathogenic mechanisms leading to the development of insulin resistance. With the completion of our research, we anticipate a better understanding of the cellular mechanisms by which insulin resistance develops and the role of botanicals in modulating the progression to metabolic syndrome.

KW - Anthocyanins

KW - Artemisia dracunculus L

KW - Botanicals

KW - Insulin

KW - Insulin resistance

KW - Shilianhua

UR - http://www.scopus.com/inward/record.url?scp=38949166054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949166054&partnerID=8YFLogxK

U2 - 10.1093/ajcn/87.2.481s

DO - 10.1093/ajcn/87.2.481s

M3 - Article

C2 - 18258643

SN - 0002-9165

VL - 87

SP - 481S-487S

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

IS - 2

ER -

Botanicals and the metabolic syndrome

Abstract

ASJC Scopus subject areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this